Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities
Basic MaterialsChemicals
  • Price (GBX)3,565.00
  • Today's Change20.00 / 0.56%
  • Shares traded1.05m
  • 1 Year change-21.80%
  • Beta0.8174
Data delayed at least 15 minutes, as of Nov 25 2024 17:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Croda International Plc is a United Kingdom-based specialty chemicals company. The Company uses its smart science to create high performance ingredients and technologies that improve people's lives. Its sales, marketing and research activities are organized into three global market sectors: consumer care, life sciences and industrial specialties. Its consumer care sector's business units comprise beauty actives, fragrances and flavors, beauty care, and home care. It a has large actives portfolio across two ranges: Sederma Actives and Croda Botanicals. The beauty care delivers differentiated ingredients across skin, hair and solar care. The Company's life sciences sector's business units comprise agriculture (crop protection and seed enhancement) and pharma. The crop protection unit offers ingredients that improve performance and delivery of crop formulations. The pharma comprises three technology platforms: protein/small molecule delivery; adjuvant systems, and nucleic acid delivery.

  • Revenue in GBP (TTM)1.63bn
  • Net income in GBP162.70m
  • Incorporated1925
  • Employees5.85k
  • Location
    Croda International PlcCowick HallGOOLE DN14 9AAUnited KingdomGBR
  • Phone+44 140 586 0551
  • Fax+44 140 586 1767
  • Websitehttps://www.croda.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
HEXPOL AB1.49bn171.62m2.55bn5.01k15.552.5411.941.716.896.8959.8442.200.87917.046.574,077,349.0010.1311.1513.9814.8622.2520.9711.5211.560.652518.030.182867.44-0.88579.871.658.9327.0021.67
Johnson Matthey PLC12.84bn108.00m2.59bn11.69k25.711.168.640.20190.58620.586269.7012.941.928.188.311,099,101.001.622.682.724.757.226.680.84091.270.97114.640.38570.86-14.003.63-59.09-23.534.10-2.07
SOL SpA1.27bn117.24m2.75bn7.02k23.443.4211.072.161.561.5616.8810.660.79543.833.31240,264.807.687.4010.059.5674.6772.959.669.301.8315.410.394222.137.8312.289.0122.9515.6016.15
Solvay SA2.95bn-222.78m2.75bn22.00k--2.5912.530.9318-2.5714.7733.6512.060.26852.372.74161,423.80-1.330.7383-1.860.9515.4624.20-4.961.491.026.960.62141,903.46-24.50-11.82-116.21--5.02-8.31
Wacker Chemie AG4.87bn103.41m3.07bn16.56k28.310.78886.340.63072.502.50118.0389.880.66123.206.45357,968.001.635.162.026.2914.7221.652.466.601.51--0.280466.04-22.015.16-74.934.979.373.71
Clariant AG3.72bn103.55m3.24bn10.57k31.151.659.220.87070.35060.247212.636.630.69183.806.43397,194.902.641.443.642.0829.2829.653.822.251.05--0.4736397.72-15.79-0.1229226.32-3.04-4.23-5.25
Sodas Sodyum Sanayii AS5.43m254.76k3.78bn--14,857.141,109.857,578.32696.640.00740.00740.15680.09841.527.1618.09--7.1525.338.6131.1524.8528.924.6918.313.75--0.0064---17.1046.4970.0540.7624.54--
Arkema SA7.89bn287.62m4.73bn21.10k16.230.77484.990.59934.614.61126.4796.550.67035.516.76453,213.002.635.993.187.2320.4521.463.927.591.548.880.371631.72-17.631.54-57.64-9.822.786.96
Croda International Plc1.63bn162.70m4.95bn5.85k30.422.1316.663.041.171.1711.6716.620.45772.364.53278,451.804.6010.805.1112.5143.8646.4110.0518.641.6710.590.234943.44-18.904.09-73.66-6.4212.784.11
Yara International ASA11.13bn437.19m5.78bn18.00k13.220.94474.550.519323.8223.82606.49333.340.87123.498.348,582,713.003.455.304.446.9727.2326.693.965.600.96276.370.369994.60-35.443.60-98.27-21.30-2.76-8.10
Syensqo NV-83.13bn-83.13bn6.24bn13.05k--1.01----------70.43------------------------1.08--0.2239---13.02---79.68------
Evonik Industries AG12.60bn189.53m6.82bn33.58k36.630.90926.330.54070.48030.480332.0219.350.75144.228.64453,859.801.212.011.542.4225.2525.471.612.900.73719.950.3168130.72-17.422.85-186.27---3.510.3454
Imcd NV3.77bn233.46m6.89bn5.01k28.414.5620.301.824.934.9379.7430.721.085.535.22958,630.506.667.019.669.6022.3721.406.195.800.88465.670.508744.25-3.4513.30-6.6523.9124.0922.87
Brenntag SE13.46bn452.63m7.28bn17.70k16.502.009.890.54083.673.67109.0730.281.498.206.72914,269.605.106.407.309.0224.6623.033.414.021.0410.120.434837.40-13.456.03-19.389.1812.4711.84
Data as of Nov 25 2024. Currency figures normalised to Croda International Plc's reporting currency: UK Pound GBX

Institutional shareholders

36.64%Per cent of shares held by top holders
HolderShares% Held
Norges Bank Investment Managementas of 31 Oct 202411.33m8.11%
The Vanguard Group, Inc.as of 01 Nov 20247.05m5.05%
Massachusetts Financial Services Co.as of 11 Jun 20246.98m5.00%
Mawer Investment Management Ltd.as of 31 Dec 20216.44m4.61%
RBC Global Asset Management (UK) Ltd.as of 31 Dec 20225.01m3.59%
Impax Asset Management Ltd.as of 01 Nov 20243.35m2.40%
Royal London Asset Management Ltd.as of 01 Nov 20243.23m2.31%
MFS International (UK) Ltd.as of 01 Nov 20242.99m2.14%
BlackRock Fund Advisorsas of 01 Nov 20242.77m1.99%
Legal & General Investment Management Ltd.as of 01 Nov 20242.01m1.44%
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.